Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed CEO foresees clear route to completion on new Allergan merger deal

This article was originally published in Clinica

Executive Summary

Botox-developer Allergan has signed a definitive agreement to acquire Inamed, just over a month after it made its takeover bid for the breast implant maker. Medicis Pharmaceuticals, with whom Inamed had a previous merger contract, bowed out of a potential bidding war with Allergan and accepted the $90m break-up fee from Inamed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058262

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel